Abviva receives new patent grant notifications for MSA technology

[News]

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, today provided further details about worldwide patent protection for its breast cancer risk assessment technology.

More... (http://www.news-medical.net/news/20100524/Abviva-receives-new-patent-grant-notifications-for-MSA-technology.aspx)